ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase

New CBIZ State of Healthcare Report Reveals Cost Increases, Significant Impact of GLP-1 Drugs on Pharmacy Spend, and Regulatory Changes Expanding Employee Protections and Accessibility

CBIZ, Inc. (NYSE: CBZ), a leading national professional services advisor, announced the release of its 2025 State of Healthcare Report. The report provides a data-driven look at trends affecting employer-sponsored healthcare and the strategies organizations are using to stay competitive.

Now, more than ever, employers face increased pressure to balance affordability with employee wellbeing as healthcare costs continue to rise. The State of Healthcare Report draws on CBIZ’s proprietary data from more than 290,000 plan members, delivering insights into care delivery, cost containment, and regulatory compliance.

Key insights from the report:

  • Healthcare costs continue to rise, with CBIZ data finding that cost per visit for inpatient, outpatient, and professional care increased from 2022 to 2024.
  • CBIZ data shows that GLP-1s are a significant cost driver in employers’ pharmacy spend. GLP-1 spend as a percentage of overall pharmacy spend has increased from 9% in 2022 to 17% in 2024. This trend is expected to continue as these medications grow in popularity.
  • Ongoing regulatory changes, specifically those occurring at the state level, are shifting employer-sponsored healthcare. Many of these regulations expand protections and accessibility for employees, and employers must continue to monitor relevant legislation to maintain compliance.

“Healthcare has never been more complex than it is right now,” said Cole Harris, Business Unit President, National Practice Leader for Health Innovations. “The report is designed to give employers real data-driven insights and forward-looking guidance to navigate our increasingly complex environment.”

The State of Healthcare Report provides a high-level overview of emerging risks and opportunities, featuring analysis from our experts on how to proactively tackle these challenges through data, innovation, and smarter benefits design.

To download the full report, visit 2025 State of Healthcare Report

About CBIZ

CBIZ, Inc. (NYSE: CBZ) is a leading professional services advisor to middle market businesses and organizations nationwide. With unmatched industry knowledge and expertise in accounting, tax, advisory, benefits, insurance, and technology, CBIZ delivers forward-thinking insights and actionable solutions to help clients anticipate what's next and discover new ways to accelerate growth. CBIZ has more than 10,000 team members across more than 160 locations in 22 major markets coast to coast. For more information, visit www.cbiz.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.